Filter
2186
Filtered Results: 2186
Text search:
medicines
financing
Featured
Recommendations
159
New Publications
706
Language
Document type
No document type
1283
Studies & Reports
449
Guidelines
164
Strategic & Response Plan
139
Manuals
93
Fact sheets
21
Situation Updates
15
Training Material
12
Infographics
5
Resource Platforms
4
Brochures
1
Countries / Regions
Global
110
Kenya
95
Sierra Leone
56
Uganda
56
Ethiopia
55
Liberia
51
Western and Central Europe
50
India
49
Nigeria
47
Africa
43
Malawi
42
Zambia
41
Myanmar / Burma
41
Ghana
40
Nepal
39
Ukraine
39
Bangladesh
36
Rwanda
35
South Africa
34
Latin America and the Carribbean
31
Tanzania
31
Eastern Europe
29
Asia
21
Namibia
21
South–East Asia Region
17
Zimbabwe
16
Philippines
16
East and Southern Africa
16
Mozambique
15
Cambodia
15
Lesotho
14
Syria
13
Senegal
13
Congo, Democratic Republic of
13
Botswana
13
Guinea
12
Haiti
12
West and Central Africa
12
Indonesia
12
Middle East and North Africa
10
Cameroon
9
Venezuela
8
Eastern Europe and Central Asia
8
Russia
8
Eswatini/ Swaziland
8
Pakistan
8
Benin
7
Burkina Faso
7
Afghanistan
6
Paraguay
6
Moldova
6
Sudan
6
Tajikistan
5
Western Pacific Region
5
Yemen
5
Georgia
5
South Sudan
5
Somalia
5
North Macedonia
4
Thailand
4
Laos
4
Jordan
4
Germany
4
Vietnam
4
Gambia
3
Albania
3
Peru
3
North America
3
Lebanon
3
Brazil
3
Ecuador
3
Turkey
2
Kazakhstan
2
Chile
2
Iran
2
Kyrgyzstan
2
Qatar
2
Jamaica
2
Southern Africa
2
Bolivia
2
Sri Lanka
2
Egypt
2
Palestine
2
Central African Republic
2
Libya
2
Colombia
1
Timor Leste/ East Timor
1
China
1
Niger
1
Uzbekistan
1
Mongolia
1
Bulgaria
1
Armenia
1
USA
1
Lithuania
1
Saudi Arabia
1
Turkmenistan
1
Japan
1
Belgium
1
Mauritius
1
Bosnia and Herzegovina
1
Papua New Guinea
1
Djibouti
1
Mali
1
Chad
1
Iraq
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
960
Public Health
156
Clinical Guidelines
109
Women & Child Health
87
Key Resources
73
Pharmacy & Technologies
14
Capacity Building
9
Annual Report MEDBOX
1
Toolboxes
HIV
183
TB
169
COVID-19
139
Mental Health
107
Planetary Health
77
AMR
73
Global Health Education
71
Health Financing Toolbox
59
Disability
53
Caregiver
52
Conflict
48
Pharmacy
47
Rapid Response
45
NCDs
40
Ebola
37
NTDs
28
Refugee
23
Natural Hazards
22
Polio
8
Cholera
7
Social Ethics
4
Zika
3
Specific Hazards
2
Health Financing
2
UNAIDS 2018 / Guidance
Guidance for policy-makers, and people living with, at risk of or affected by HIV
Accountability for the global health sector strategies, 2016–2021
WHO/CDS/HIV/19.7
Agenda item 5, UNAIDS/PCB (43)/18.
11-13 December 2018 | Geneva, Switzerland
UNAIDS Programme Coordinating Board
Issue date: 23 November 2018
UNAIDS Joint United Nations Programme on HIV/AIDS
This is the first national Policy to combat AMR in Cambodia. It was developed based on conclusions and recommendations of a country situaytion analysis.
Ramped-up cancer services could save 7 million lives over the next decade—and addressing huge service gaps between rich and poor countries is key to success, according to this report.
In 2019, over 90% of high-income countries reported that comprehensive cancer treatment services were available...
Antimicrobial resistance (AMR) is a global threat that requires urgent collaborative action within and among countries. AMR makes standard treatments ineffective and facilitates the spread of antimicrobial resistant infections rendering communities vulnerable. The Ministry of Health (MOH) and Minist...
Antimicrobial resistance is a global crisis that threatens a century of progress in health and achievement of the Sustainable Development Goals. There is no time to wait. Unless the world acts urgently, antimicrobial resistance will have disastrous impact within a generation.
The threat posed by antimicrobial resistance (AMR) to public health as well as global health security has been reiterated in umerous World Health Assembly (WHA) resolutions. AMR is also prioritized under the Global Health Security Agenda (GHSA), and India is one of the contributing countries. The Mi...
This FY 2019 Malaria Operational Plan presents a detailed implementation plan for Burkina Faso, based on the strategies of PMI and the National Malaria Control Program (NMCP). It was developed in consultation with the NMCP and with the participation of national and international partners involved in...
The most significant finding of the case study for integrating antimicrobial resistance (AMR)into existing programs and mobilising resources for funding in Nigeria, is that most of the AMR activities within the Nigerian National Action Plan (NAP)canalready be incorporated within exi...
WHO would like to express its gratitude and appreciation to all Member States that provided information to the WHO survey on policies and activities at the national level in the area of antimicrobial resistance. The contribution of staff in WHO Regional and Country Offices has been invaluable: in ga...
The Global Antibiotic Resistance Partnership (GARP)-Mozambique team, in partnership with the Center for Disease Dynamics, Economics & Policy (CDDEP), has produced this report as part of a solid com-mitment to develop actionable policy proposals to tackle antibiotic resistance and improve appropriate...
The objectives of NAP are aligned with the global action plan based on national needs and priorities. The emphasis is on One Health approach with all sectors especially human health, animal health and environment contributing towards minimizing the emergence and impact of AMR in Jordan.
Antimicrobials have been a critical public health tool since the discovery of penicillin in 1928, saving the lives of millions of people around the world. Today, however, the emergence of drug resistance is reversing the miracles of the past eighty years, with drug choices for the treatment of many ...
The ECA, says over 300,000 Africans could lose their lives due to COVID-19. This, as the pandemic continues to impact on the Continent’s struggling economies whose growth is expected to slow down from 3.2 percent to 1.8 percent in a best-case scenario, pushing close to 27 million people into extr...
While much progress has been achieved over the past year, the Region of the Americas has stubbornly remained the epicenter of the COVID-19 pandemic. PAHO is launching its 2021 COVID-19 Response Strategy and Donor Appeal to continue supporting Latin American and Caribbean countries and territories i...
The two-year impact report for the Access to COVID-19 Tools (ACT) Accelerator details impact, case studies and timelines of key milestones for the Diagnostics, Therapeutics and Vaccines pillars, as well as the Health Systems and Response Connector.
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
